GoldBamboo.com - Knowledge is strong medicine
  

Evaluation of the Effects of Response Elaboration Training for Aphasia - Article


  Not Signed In - Sign In / Register







[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Speech Disorders




Clinical Trial: Evaluation of the Effects of Response Elaboration Training for Aphasia

This study is currently recruiting patients.
Verified by Department of Veterans Affairs December 2004

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00125216

Purpose

The purpose of this study is to evaluate the effects of Response Elaboration Training (RET), which is a speech/language therapy for aphasia. The study is designed to determine verbal language production improves in terms of content and length of utterances as a result of treatment.
Condition Intervention
Aphasia
Speech Disorders
Language Disorders
 Behavior: Response Elaboration Training

MedlinePlus related topics:  Aphasia;   Speech and Communication Disorders

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Further Study Details: 
Primary Outcomes: Production of content in discourse at 6 weeks following; completion of treatment.
Secondary Outcomes: Production of content and mean length of utterance; in 1) picture descriptions, 2) story retells, 3); conversations with familiar speaking partners, and; 4) 5 minute monologues. Measures will be taken repeatedly; through all phases of the study and at 3 and 6 weeks post-; treatment.
Expected Total Enrollment:  54

Study start: December 2004;  Expected completion: June 2008
Last follow-up: December 2007;  Data entry closure: December 2007

Detailed Description Extended description of the protocol, including information not already contained in other fields, such as comparison(s) studied.

Example Sudden out-of-hospital cardiac arrest (OOH-CA) remains a significant cause of death, in spite of recent declines in overall mortality from cardiovascular disease. Existing methods of emergency resuscitation are inadequate due to time delays inherent in the transport of a trained responder with defibrillation capabilities to the side of the OOH-CA victim. Existing Emergency Medical Services (EMS) systems typically combine paramedic Emergency Medical Technician (EMT) services with some level of community involvement, such as bystander cardiopulmonary resuscitation (CPR) training. Some communities include automated external defibrillators (AEDs) at isolated sites or in mobile police or fire vehicles. A comprehensive, integrated community approach to treatment with AEDs would have community units served by these volunteer non-medical responders who can quickly identify and treat a patient with OOH-CA. Such an approach is termed Public Access Defibrillation (PAD).

Comparison(s): Community units trained and equipped to provide public access defibrillation in addition to optimal standard care, compared to community units trained to provide optimal standard care (recognition of out-of-hospital cardiac arrest, 911 access, and cardiopulmonary resuscitation).

(May insert all of study abstract)

The purpose of the proposed research is to thoroughly evaluate the effects of Response Elaboration Training (RET with persons with aphasia. Specifically, the proposed research investigation is designed to delineate the outcomes that may be expected with RET. The study is also designed to improve outcomes in the area of stimulus generalization effects of treatment by testing a modification of RET designed to facilitate generalization. The specific experimental questions to be addressed are as follows: 1. Will RET result in increased production of correct information units and increased length and changes in composition of utterances as measured in a) trained and untrained picture descriptions, b) story retells, c) conversations with significant others/family members/friends, and d) personal recounts? 2. Will modification and extension of RET to additional training contexts result in further increases in production of CIUs and increased length and complexity of utterances? 3. Will the effects* of RET vary among participants with fluent aphasia, participants with nonfluent aphasia who present with mild to moderate verbal production deficits, and participants with nonfluent aphasia who present with severe verbal production deficits? * effects = effects on production of CIUs and on measures of functional communication 4. Will changes in measures of functional communication be observed following administration of RET? A series of single-subject experimental designs across subjects, behaviors, and contexts will be conducted to address these questions. Twenty-four adults with chronic, moderate to severe aphasia secondary to unilateral, left-hemisphere brain-injury will serve as participants for this investigation.

Eligibility

Ages Eligible for Study:  21 Years and above,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria: • Diagnosis of moderate to severe nonfluent or fluent aphasia • Nonverbal intelligence within normal limits • Auditory and visual acuity adequate for experimental tasks • 6 months post-onset of single, focal brain injury (e.g., stroke) -

Exclusion Criteria: • Previous history of therapy with RET • Diagnosed psychological disorder other than depression • Neurological condition other than that which resulted in aphasia • History of alcohol or substance abuse • Non-native English speaker • Premorbid history of speech/language disorder -

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00125216

Reuben T Walize, MPH      801-582-1565  Ext. 4857    reuben.walize@med.va.gov
Laurence J Meyer, MD, Ph.D.      801-582-1565    laurence.meyer@med.va.gov

Utah
      VA Salt Lake City Healthcare System, Salt Lake City,  Utah,  84148,  United States; Recruiting
Reuben T Walize, MPH  801-582-1565  Ext. 4857    reuben.walize@med.VA.gov 
Laurence J Meyer, MD, Ph.D.  801-582-1565    laurence.meyer@med.va.gov 

Study chairs or principal investigators

Julie L Wambaugh, Ph.D.,  Principal Investigator,  VA Salt Lake City Healthcare System   

More Information

Study ID Numbers:  C3719R
Last Updated:  August 1, 2005
Record first received:  July 29, 2005
ClinicalTrials.gov Identifier:  NCT00125216
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-08-02

Resources

  • (National Women's Health Information Center, OWH, HHS)
  • Apraxia of Speech (National Institute on Deafness and Other Communication Disorders)


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Speech Disorders.

January 9, 2009



Page Updated: September 6, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Gold Bamboo LLC - All rights reserved. [new]

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.